The Quality Standards Resource Centre helps extend understanding of the strengthened Aged Care Quality Standards, which take effect from 1 November 2025. The Resource Centre will be updated to reflect key changes made to the draft strengthened Standards. You can search for resources by using keywords, or filtering by standard, outcome, audience and theme. Before using the Resource Centre, please read the terms of use.
Kimberley Indigenous Cognitive Assessment (KICA)
The Kimberley Indigenous Cognitive Assessment (KICA) is a cognitive screening tool for older Aboriginal Australians living in rural and remote areas. It has been adapted for use with Torres Strait Islander people, and for Aboriginal people living in urban and regional areas.
This resource was developed by a state/territory government or organisation and therefore its applicability and usefulness may be limited.
Participating with consumers
This resource provides information sheets for residents, families, and carers to support decision-making in residential aged care. Covering topics such as pain management, falls, and medicines, it promotes health literacy, enabling consumers to engage in discussions and report care issues effectively.
This resource was developed by a state/territory government or organisation and therefore its applicability and usefulness may be limited.
Delirium Clinical Care Standard
This resource outlines the Australian Commission on Safety and Quality in Health Care's Delirium Clinical Care Standard, which aims to improve the prevention, early diagnosis, and treatment of delirium. It includes 8 evidence-based quality statements and indicators for safe care. The standard helps clinicians and healthcare organisations manage cognitive impairment, with relevance to both hospital and aged care settings.
This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
Safe and appropriate use of psychotropic medicines for aged care - Fact sheet
This fact sheet is informed by the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard (CCS), developed by the Australian Commission on Safety and Quality in Health Care. The CCS describes the safe and appropriate use of psychotropic medicines for people with cognitive disability or impairment, in a way that upholds their rights, dignity, health and quality of life.
This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
